Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Marquet

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Annales De Medecine Interne|January 1, 1979
[Epidemiology of asbestos-induced mesotheliomas in inhabitants of the Saint-Etienne area. Apropos of 35 cases]A Emonot, M Marquet, A Baril, et al.
Molecular & General Genetics : MGG|March 19, 1973
Carbohydrate metabolism and transport in Bacillus subtilis. A study of ctr mutationsP Gay, P Cordier, M Marquet, et al.
Human Gene Therapy|June 13, 1998
Quantitation of host cell DNA contaminate in pharmaceutical-grade plasmid DNA using competitive polymerase chain reaction and enzyme-linked immunosorbent assayR Lahijani, M Duhon, E Lusby, et al.
Annales De Medecine Interne|June 1, 1976
[Acute reversible agranulocytosis due to cephalexin therapy]M Le Porrier, M Marquet, A Prier, et al.
Human Gene Therapy|May 1, 1995
Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trialsN A Horn, J A Meek, G Budahazi, et al.
Revue De L'Infirmiere|April 15, 2000
[Collecting devices and skin protectors]G Bôll, M Conge, M Guyot, et al.
Revue De L'Infirmiere|April 15, 2000
[The enterostoma therapists]G Bôll, M Conge, M Guyot, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|July 27, 1970
[Demonstration of phosphotransferase systems in the transport of glucose, fructose and saccharose in Bacillus subtilis]M Marquet, M C Wagner, A Delobbe, et al.
Human Gene Therapy|May 1, 1995
Preclinical pharmacokinetics, manufacturing, and safety studies supporting a multicenter cancer gene therapy trialJ A Norman, S Parker, D Lew, et al.
Human Gene Therapy|October 20, 1996
High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutationR Lahijani, G Hulley, G Soriano, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Annales De Medecine Interne|January 1, 1979
[Epidemiology of asbestos-induced mesotheliomas in inhabitants of the Saint-Etienne area. Apropos of 35 cases]A Emonot, M Marquet, A Baril, et al.
Molecular & General Genetics : MGG|March 19, 1973
Carbohydrate metabolism and transport in Bacillus subtilis. A study of ctr mutationsP Gay, P Cordier, M Marquet, et al.
Human Gene Therapy|June 13, 1998
Quantitation of host cell DNA contaminate in pharmaceutical-grade plasmid DNA using competitive polymerase chain reaction and enzyme-linked immunosorbent assayR Lahijani, M Duhon, E Lusby, et al.
Annales De Medecine Interne|June 1, 1976
[Acute reversible agranulocytosis due to cephalexin therapy]M Le Porrier, M Marquet, A Prier, et al.
Human Gene Therapy|May 1, 1995
Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trialsN A Horn, J A Meek, G Budahazi, et al.
Revue De L'Infirmiere|April 15, 2000
[Collecting devices and skin protectors]G Bôll, M Conge, M Guyot, et al.
Revue De L'Infirmiere|April 15, 2000
[The enterostoma therapists]G Bôll, M Conge, M Guyot, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|July 27, 1970
[Demonstration of phosphotransferase systems in the transport of glucose, fructose and saccharose in Bacillus subtilis]M Marquet, M C Wagner, A Delobbe, et al.
Human Gene Therapy|May 1, 1995
Preclinical pharmacokinetics, manufacturing, and safety studies supporting a multicenter cancer gene therapy trialJ A Norman, S Parker, D Lew, et al.
Human Gene Therapy|October 20, 1996
High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutationR Lahijani, G Hulley, G Soriano, et al.
Pageof 4